We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biological Deviation Reports May Spur ‘Direct’ Recall: CBER Officials
Biological Deviation Reports May Spur ‘Direct’ Recall: CBER Officials
September 4, 2012
TAMPA, Fla. — Now that CBER’s all-electronic Direct Recall Classification (DRC) program has been extended to non-blood products, problems with biologic drugs flagged in electronic biological product deviation reports (eBPDRs) may trigger recalls of those products under the program.